Trade Artivion Inc - AORT CFD
Add to favourite- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
- Cash Flow
- Ownership
Spread | 0.17 | ||||||||
Long position overnight fee
Long position overnight fee
Go to platform | -0.030779% | ||||||||
Short position overnight fee
Short position overnight fee
Go to platform | -0.013666% | ||||||||
Overnight fee time | 22:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | USD | ||||||||
Margin | 20% | ||||||||
Stock exchange | United States of America | ||||||||
Commission on trade | 0% |
*Information provided by Capital.com
Prev. Close* | 14.09 |
Open* | 13.7 |
1-Year Change* | -20.35% |
Day's Range* | 13.7 - 14.42 |
52 wk Range | 9.64-23.43 |
Average Volume (10 days) | 120.81K |
Average Volume (3 months) | 3.65M |
Market Cap | 565.82M |
P/E Ratio | -100.00K |
Shares Outstanding | 40.33M |
Revenue | 313.79M |
EPS | -1.04 |
Dividend (Yield %) | N/A |
Beta | 1.40 |
Next Earnings Date | Feb 16, 2023 |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Feb 3, 2023 | 14.00 | 0.24 | 1.74% | 13.76 | 14.44 | 13.48 |
Feb 2, 2023 | 14.09 | 1.19 | 9.22% | 12.90 | 14.10 | 12.79 |
Feb 1, 2023 | 13.07 | 0.20 | 1.55% | 12.87 | 13.32 | 12.62 |
Jan 31, 2023 | 13.01 | 1.05 | 8.78% | 11.96 | 13.02 | 11.94 |
Jan 30, 2023 | 12.34 | 0.30 | 2.49% | 12.04 | 12.62 | 12.04 |
Jan 27, 2023 | 12.43 | 0.47 | 3.93% | 11.96 | 12.64 | 11.80 |
Jan 26, 2023 | 12.42 | 0.00 | 0.00% | 12.42 | 12.60 | 12.08 |
Jan 25, 2023 | 12.60 | 0.27 | 2.19% | 12.33 | 12.66 | 12.33 |
Jan 24, 2023 | 12.75 | 0.10 | 0.79% | 12.65 | 13.16 | 12.42 |
Jan 23, 2023 | 12.83 | 0.28 | 2.23% | 12.55 | 12.98 | 12.27 |
Jan 20, 2023 | 12.60 | 0.08 | 0.64% | 12.52 | 12.78 | 12.28 |
Jan 19, 2023 | 12.44 | 0.12 | 0.97% | 12.32 | 12.55 | 12.18 |
Jan 18, 2023 | 12.29 | -0.39 | -3.08% | 12.68 | 13.06 | 12.29 |
Jan 17, 2023 | 12.70 | 0.36 | 2.92% | 12.34 | 12.97 | 12.28 |
Jan 13, 2023 | 12.67 | 0.31 | 2.51% | 12.36 | 12.91 | 12.27 |
Jan 12, 2023 | 12.74 | 0.52 | 4.26% | 12.22 | 13.01 | 12.11 |
Jan 11, 2023 | 12.60 | 0.10 | 0.80% | 12.50 | 13.16 | 12.37 |
Jan 10, 2023 | 13.05 | 0.83 | 6.79% | 12.22 | 13.11 | 11.89 |
Jan 9, 2023 | 12.29 | 0.13 | 1.07% | 12.16 | 12.55 | 12.02 |
Jan 6, 2023 | 12.32 | -0.02 | -0.16% | 12.34 | 12.67 | 11.89 |
Artivion Inc Events
Time (UTC) | Country | Event |
---|---|---|
No events scheduled |
- Annual
- Quarterly
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Total revenue | 180.38 | 189.702 | 262.841 | 276.222 | 253.227 | 298.836 |
Revenue | 180.38 | 189.702 | 262.841 | 276.222 | 253.227 | 298.836 |
Cost of Revenue, Total | 61.481 | 61.06 | 89.857 | 93.209 | 85.443 | 101.322 |
Gross Profit | 118.899 | 128.642 | 172.984 | 183.013 | 167.784 | 197.514 |
Total Operating Expense | 158.56 | 181.732 | 253.529 | 259.18 | 250.786 | 307.116 |
Selling/General/Admin. Expenses, Total | 91.548 | 101.211 | 122.382 | 128.061 | 121.172 | 131.358 |
Research & Development | 13.446 | 19.461 | 23.098 | 22.96 | 24.207 | 35.546 |
Unusual Expense (Income) | -7.915 | 0 | 7.4 | 4.1 | 6.2 | 21.474 |
Operating Income | 21.82 | 7.97 | 9.312 | 17.042 | 2.441 | -8.28 |
Interest Income (Expense), Net Non-Operating | -2.971 | -4.669 | -15.562 | -14.148 | -16.481 | -21.834 |
Other, Net | -0.437 | 0.26 | -0.141 | -1.25 | -3.134 | -0.636 |
Net Income Before Taxes | 18.412 | 3.561 | -6.391 | 1.644 | -17.174 | -14.827 |
Net Income After Taxes | 10.778 | 3.449 | -3.078 | 1.565 | -16.682 | -14.834 |
Net Income Before Extra. Items | 10.778 | 3.449 | -3.078 | 1.565 | -16.682 | -14.834 |
Net Income | 10.778 | 3.704 | -2.84 | 1.72 | -16.682 | -14.834 |
Total Adjustments to Net Income | -0.208 | -0.063 | 0.027 | -0.012 | 0.111 | 0.094 |
Income Available to Common Excl. Extra. Items | 10.57 | 3.386 | -3.051 | 1.553 | -16.571 | -14.74 |
Income Available to Common Incl. Extra. Items | 10.57 | 3.641 | -2.813 | 1.708 | -16.571 | -14.74 |
Dilution Adjustment | 0.006 | 0.002 | ||||
Diluted Net Income | 10.576 | 3.643 | -2.813 | 1.708 | -16.571 | -14.74 |
Diluted Weighted Average Shares | 32.822 | 34.163 | 36.412 | 37.86 | 37.861 | 38.983 |
Diluted EPS Excluding Extraordinary Items | 0.32222 | 0.09917 | -0.08379 | 0.04102 | -0.43768 | -0.37811 |
Dividends per Share - Common Stock Primary Issue | 0 | |||||
Diluted Normalized EPS | 0.18106 | 0.09917 | 0.04831 | 0.14411 | -0.30205 | -0.28556 |
Total Extraordinary Items | 0.255 | 0.238 | 0.155 | |||
Depreciation / Amortization | 10.792 | 10.85 | 13.764 | 17.416 | ||
Gain (Loss) on Sale of Assets | 15.923 |
Q1 2021 | Q2 2021 | Q3 2021 | Q4 2021 | Q1 2022 | |
---|---|---|---|---|---|
Total revenue | 71.087 | 147.235 | 72.207 | 79.394 | 77.213 |
Revenue | 71.087 | 147.235 | 72.207 | 79.394 | 77.213 |
Cost of Revenue, Total | 23.249 | 48.884 | 24.418 | 28.02 | 26.494 |
Gross Profit | 47.838 | 98.351 | 47.789 | 51.374 | 50.719 |
Total Operating Expense | 69.641 | 144.94 | 73.443 | 88.733 | 76.051 |
Selling/General/Admin. Expenses, Total | 32.724 | 65.86 | 33.36 | 32.138 | 36.334 |
Research & Development | 7.754 | 16.114 | 9.972 | 9.46 | 10.128 |
Depreciation / Amortization | 4.414 | 8.808 | 4.393 | 4.215 | 4.221 |
Unusual Expense (Income) | 1.5 | 5.274 | 1.3 | 14.9 | -1.126 |
Operating Income | 1.446 | 2.295 | -1.236 | -9.339 | 1.162 |
Interest Income (Expense), Net Non-Operating | -4.016 | -8.379 | -4.082 | -3.873 | -3.458 |
Other, Net | -1.931 | -0.6 | -2.661 | -2.875 | -0.133 |
Net Income Before Taxes | -4.501 | -6.684 | 7.944 | -16.087 | -2.429 |
Net Income After Taxes | -3.138 | -5.316 | 10.582 | -20.1 | -3.389 |
Net Income Before Extra. Items | -3.138 | -5.316 | 10.582 | -20.1 | -3.389 |
Net Income | -3.138 | -5.316 | 10.582 | -20.1 | -3.389 |
Total Adjustments to Net Income | 0.023 | 0.029 | -0.063 | 0.128 | 0.018 |
Income Available to Common Excl. Extra. Items | -3.115 | -5.287 | 10.519 | -19.972 | -3.371 |
Income Available to Common Incl. Extra. Items | -3.115 | -5.287 | 10.519 | -19.972 | -3.371 |
Diluted Net Income | -3.115 | -5.287 | 10.519 | -19.972 | -3.371 |
Diluted Weighted Average Shares | 38.738 | 41.9745 | 44.453 | 39.16 | 39.85 |
Diluted EPS Excluding Extraordinary Items | -0.08041 | -0.12596 | 0.23663 | -0.51001 | -0.08459 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
Diluted Normalized EPS | -0.05524 | -0.04429 | 0.02281 | -0.26269 | -0.10296 |
Gain (Loss) on Sale of Assets | 0 | 15.923 | 0 |
- Annual
- Quarterly
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Total Current Assets | 147.233 | 179.28 | 179.168 | 187.39 | 234.589 | 247.697 |
Cash and Short Term Investments | 56.642 | 39.977 | 41.489 | 33.766 | 61.412 | 55.01 |
Cash & Equivalents | 56.642 | 39.977 | 41.489 | 33.766 | 61.412 | 55.01 |
Total Receivables, Net | 30.096 | 51.441 | 51.432 | 55.861 | 48.752 | 58.105 |
Accounts Receivable - Trade, Net | 27.769 | 47.525 | 47.108 | 52.94 | 45.964 | 53.019 |
Total Inventory | 26.293 | 46.684 | 45.478 | 53.071 | 73.038 | 76.971 |
Prepaid Expenses | 2.815 | 4.731 | 6.848 | 11.613 | 14.295 | 14.748 |
Other Current Assets, Total | 31.387 | 36.447 | 33.921 | 33.079 | 37.092 | 42.863 |
Total Assets | 316.14 | 589.693 | 571.091 | 605.654 | 789.404 | 793.052 |
Property/Plant/Equipment, Total - Net | 18.502 | 33.579 | 31.028 | 54.144 | 51.648 | 83.235 |
Property/Plant/Equipment, Total - Gross | 73.737 | 93.095 | 95.598 | 130.101 | 138.825 | 177.76 |
Accumulated Depreciation, Total | -55.235 | -59.516 | -64.57 | -75.957 | -87.177 | -94.525 |
Goodwill, Net | 78.294 | 188.305 | 188.781 | 186.697 | 260.061 | 250 |
Intangibles, Net | 66.641 | 179.43 | 160.081 | 157.734 | 227.057 | 201.496 |
Other Long Term Assets, Total | 5.47 | 9.099 | 12.033 | 19.689 | 16.049 | 10.624 |
Total Current Liabilities | 30.102 | 42.94 | 34.523 | 45.195 | 60.468 | 44.953 |
Accounts Payable | 5.744 | 9.767 | 7.547 | 9.796 | 9.623 | 10.395 |
Accrued Expenses | 18.675 | 25.431 | 21.234 | 28.842 | 27.046 | 27.688 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 4.562 | 1.296 | 1.889 | 1.761 | 1.809 | 2.158 |
Other Current Liabilities, Total | 1.121 | 6.446 | 3.853 | 4.796 | 21.99 | 4.712 |
Total Liabilities | 107.157 | 312.635 | 296.024 | 319.958 | 460.691 | 492.324 |
Total Long Term Debt | 67.012 | 225.092 | 221.658 | 219.986 | 295.768 | 311.867 |
Long Term Debt | 67.012 | 218.236 | 215.721 | 214.571 | 290.468 | 307.493 |
Other Liabilities, Total | 10.043 | 14.172 | 12.576 | 28.933 | 69.742 | 106.705 |
Total Equity | 208.983 | 277.058 | 275.067 | 285.696 | 328.713 | 300.728 |
Common Stock | 0.342 | 0.376 | 0.385 | 0.39 | 0.404 | 0.414 |
Additional Paid-In Capital | 187.061 | 249.935 | 260.361 | 271.782 | 316.192 | 322.874 |
Retained Earnings (Accumulated Deficit) | 34.143 | 37.609 | 34.984 | 36.704 | 20.022 | 1.975 |
Treasury Stock - Common | -12.134 | -12.719 | -14.591 | -14.591 | -14.648 | -14.648 |
Other Equity, Total | -0.429 | 1.857 | -6.072 | -8.589 | 6.743 | -9.887 |
Total Liabilities & Shareholders’ Equity | 316.14 | 589.693 | 571.091 | 605.654 | 789.404 | 793.052 |
Total Common Shares Outstanding | 32.874 | 36.231 | 36.979 | 37.534 | 38.907 | 39.91 |
Capital Lease Obligations | 6.856 | 5.937 | 5.415 | 5.3 | 4.374 | |
Deferred Income Tax | 30.431 | 27.267 | 25.844 | 34.713 | 28.799 | |
Redeemable Preferred Stock | 0 | 0 |
Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
---|---|---|---|---|---|
Total Current Assets | 235.683 | 238.054 | 257.343 | 247.697 | 244.533 |
Cash and Short Term Investments | 56.552 | 50.473 | 64.587 | 55.01 | 51.408 |
Cash & Equivalents | 56.552 | 50.473 | 64.587 | 55.01 | 51.408 |
Total Receivables, Net | 50.736 | 53.284 | 55.176 | 58.105 | 59.575 |
Accounts Receivable - Trade, Net | 48.32 | 49.672 | 49.682 | 53.019 | 54.998 |
Total Inventory | 73.375 | 76.362 | 78.319 | 76.971 | 76.208 |
Prepaid Expenses | 15.22 | 16.105 | 16.104 | 14.748 | 13.378 |
Other Current Assets, Total | 39.8 | 41.83 | 43.157 | 42.863 | 43.964 |
Total Assets | 794.832 | 810.497 | 818.654 | 793.052 | 781.856 |
Property/Plant/Equipment, Total - Net | 70.57 | 84.776 | 83.886 | 83.235 | 81.824 |
Property/Plant/Equipment, Total - Gross | 48.859 | 59.042 | 58.429 | 58.097 | 57.532 |
Accumulated Depreciation, Total | -9.786 | -10.683 | -11.516 | -12.383 | -13.167 |
Goodwill, Net | 253.95 | 255.484 | 252.441 | 250 | 247.829 |
Intangibles, Net | 218.238 | 215.84 | 207.789 | 201.496 | 196.155 |
Other Long Term Assets, Total | 16.391 | 16.343 | 17.195 | 10.624 | 11.515 |
Total Current Liabilities | 58.018 | 58.944 | 61.13 | 44.953 | 42.837 |
Accounts Payable | 8.952 | 10.773 | 9.528 | 10.395 | 9.23 |
Accrued Expenses | 24.158 | 23.919 | 27.43 | 27.688 | 24.535 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 1.752 | 2.216 | 2.177 | 2.158 | 1.622 |
Other Current Liabilities, Total | 23.156 | 22.036 | 21.995 | 4.712 | 7.45 |
Total Liabilities | 497.501 | 508.662 | 507.113 | 492.324 | 484.364 |
Total Long Term Debt | 314.988 | 312.91 | 312.373 | 311.867 | 311.388 |
Long Term Debt | 310.058 | 308.05 | 307.765 | 307.493 | 307.232 |
Capital Lease Obligations | 4.93 | 4.86 | 4.608 | 4.374 | 4.156 |
Deferred Income Tax | 29.272 | 29.583 | 27.339 | 28.799 | 26.373 |
Other Liabilities, Total | 95.223 | 107.225 | 106.271 | 106.705 | 103.766 |
Total Equity | 297.331 | 301.835 | 311.541 | 300.728 | 297.492 |
Common Stock | 0.406 | 0.407 | 0.408 | 0.414 | 0.417 |
Additional Paid-In Capital | 301.449 | 305.157 | 309.29 | 322.874 | 326.799 |
Retained Earnings (Accumulated Deficit) | 13.671 | 11.493 | 22.075 | 1.975 | -1.414 |
Treasury Stock - Common | -14.648 | -14.648 | -14.648 | -14.648 | -14.648 |
Other Equity, Total | -3.547 | -0.574 | -5.584 | -9.887 | -13.662 |
Total Liabilities & Shareholders’ Equity | 794.832 | 810.497 | 818.654 | 793.052 | 781.856 |
Total Common Shares Outstanding | 39.098 | 39.255 | 39.329 | 39.91 | 40.201 |
- Annual
- Quarterly
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Net income/Starting Line | 10.778 | 3.704 | -2.84 | 1.72 | -16.682 | -14.834 |
Cash From Operating Activities | 19.719 | 10.803 | 9.881 | 15.827 | 12.369 | -2.585 |
Cash From Operating Activities | 8.384 | 9.745 | 18.095 | 18.317 | 20.712 | 23.977 |
Deferred Taxes | 0.595 | -1.483 | -4.485 | -2.305 | 4.283 | -4.47 |
Non-Cash Items | 0.045 | 9.705 | 9.123 | 17.478 | 30.752 | 25.974 |
Cash Taxes Paid | 2.501 | 3.358 | 1.699 | 1.944 | 4.122 | 5.483 |
Cash Interest Paid | 2.446 | 2.561 | 15.005 | 13.297 | 13.049 | 14.407 |
Changes in Working Capital | -0.083 | -10.868 | -10.012 | -19.383 | -26.696 | -33.232 |
Cash From Investing Activities | -78.907 | -171.048 | -6.715 | -23.943 | -73.128 | 5.66 |
Capital Expenditures | -6.198 | -6.632 | -5.786 | -8.072 | -7.328 | -13.091 |
Other Investing Cash Flow Items, Total | -72.709 | -164.416 | -0.929 | -15.871 | -65.8 | 18.751 |
Cash From Financing Activities | 73.428 | 143.245 | -2.562 | -1.493 | 93.608 | -12.223 |
Financing Cash Flow Items | -1.672 | -11.054 | -1.526 | -0.728 | -1.483 | -10.98 |
Issuance (Retirement) of Stock, Net | 1.506 | 1.512 | 1.754 | 2.015 | 0.437 | 1.842 |
Issuance (Retirement) of Debt, Net | 73.594 | 152.787 | -2.79 | -2.78 | 94.654 | -3.085 |
Foreign Exchange Effects | -0.317 | 0.412 | 0.879 | 1.667 | -5.185 | 2.2 |
Net Change in Cash | 13.923 | -16.588 | 1.483 | -7.942 | 27.664 | -6.948 |
Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -3.138 | -5.316 | 5.266 | -14.834 | -3.389 |
Cash From Operating Activities | -3.039 | -0.392 | -3.301 | -2.585 | -0.598 |
Cash From Operating Activities | 6.006 | 11.999 | 18.008 | 23.977 | 5.881 |
Deferred Taxes | -4.241 | -4.269 | -8.128 | -4.47 | -2.966 |
Non-Cash Items | 7.269 | 17.602 | 8.774 | 25.974 | 4.771 |
Changes in Working Capital | -8.935 | -20.408 | -27.221 | -33.232 | -4.895 |
Cash From Investing Activities | -0.81 | -7.044 | 8.472 | 5.66 | -2.708 |
Capital Expenditures | -1.502 | -7.249 | -10.524 | -13.091 | -2.239 |
Other Investing Cash Flow Items, Total | 0.692 | 0.205 | 18.996 | 18.751 | -0.469 |
Cash From Financing Activities | -2.095 | -3.737 | -3.422 | -12.223 | -0.235 |
Financing Cash Flow Items | -0.442 | -2.822 | -2.658 | -10.98 | -0.129 |
Issuance (Retirement) of Stock, Net | -0.952 | 0.49 | 1.633 | 1.842 | 0.588 |
Issuance (Retirement) of Debt, Net | -0.701 | -1.405 | -2.397 | -3.085 | -0.694 |
Foreign Exchange Effects | 1.088 | 0.242 | 1.418 | 2.2 | -0.061 |
Net Change in Cash | -4.856 | -10.931 | 3.167 | -6.948 | -3.602 |
Investor Name | Investor Type | Percent Outstanding | Shares Held | Shares change | Holdings Date | Turnover Rating |
---|---|---|---|---|---|---|
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 15.9131 | 6417665 | -132745 | 2022-09-30 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 6.7971 | 2741250 | 38684 | 2022-09-30 | LOW |
Macquarie Investment Management | Investment Advisor | 6.4321 | 2594021 | 193189 | 2022-09-30 | LOW |
Wasatch Global Investors Inc | Investment Advisor/Hedge Fund | 5.2849 | 2131384 | -628634 | 2022-09-30 | LOW |
Juniper Investment Company, LLC | Investment Advisor/Hedge Fund | 5.1845 | 2090864 | 155000 | 2022-09-30 | LOW |
Morgan Stanley Smith Barney LLC | Investment Advisor | 4.2288 | 1705448 | 18554 | 2022-09-30 | LOW |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 3.8621 | 1557565 | -30741 | 2022-09-30 | LOW |
Dimensional Fund Advisors, L.P. | Investment Advisor/Hedge Fund | 3.5775 | 1442782 | 64469 | 2022-09-30 | LOW |
Wellington Management Company, LLP | Investment Advisor/Hedge Fund | 3.4676 | 1398473 | 1092275 | 2022-09-30 | LOW |
GW&K Investment Management, LLC | Investment Advisor | 3.3637 | 1356552 | -52952 | 2022-09-30 | LOW |
Perceptive Advisors LLC | Private Equity | 2.986 | 1204229 | 274524 | 2022-09-30 | LOW |
Royce Investment Partners | Investment Advisor/Hedge Fund | 2.2855 | 921732 | 62700 | 2022-09-30 | LOW |
Millennium Management LLC | Hedge Fund | 1.7573 | 708712 | 628174 | 2022-09-30 | HIGH |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.6666 | 672121 | 5722 | 2022-09-30 | LOW |
Kennedy Capital Management, Inc. | Investment Advisor | 1.6159 | 651681 | -13861 | 2022-09-30 | LOW |
Mackin James Patrick | Individual Investor | 1.2314 | 496635 | 116954 | 2022-11-08 | LOW |
PENN Capital Management Company, Inc. | Investment Advisor/Hedge Fund | 1.0705 | 431737 | -178798 | 2022-09-30 | MED |
ArrowMark Colorado Holdings, LLC | Investment Advisor/Hedge Fund | 1.0522 | 424340 | 22409 | 2022-09-30 | LOW |
BlackRock Financial Management, Inc. | Investment Advisor/Hedge Fund | 0.9405 | 379281 | 2077 | 2022-09-30 | LOW |
Northern Trust Investments, Inc. | Investment Advisor/Hedge Fund | 0.9107 | 367261 | -1752 | 2022-09-30 | LOW |
Why choose Capital.com? Our numbers speak for themselves.
Capital.com GroupTraders
Active clients monthly
Monthly investing volume
Withdrawn each month
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Artivion Inc Company profile
About Artivion Inc
Artivion, Inc. (Artivion), formerly CryoLife, Inc., is a medical device company. The Company is focused on developing various solutions that address cardiac and vascular surgeons' challenges in treating patients with aortic diseases. The Company's four groups of products include aortic stents and stent grafts, prosthetic heart valves, cryopreserved cardiac and vascular allografts, and surgical sealants. Artivion's cryopreserved cardiac and vascular allograft tissues help in restoring surgeries for adults and pediatric patients. It offers surgical sealant through BioGlue product. Its surgical aortic valve replacement solutions include On-X Aortic Heart Valves and CryoValve SG Pulmonary Valve Allograft for the Ross procedure. The Company's mitral valve solutions include Chord-X for mitral valve repair and On-X Mitral Heart Valve. Artivion's Cardiac and Vascular Ancillary solutions provide complementary support for the patient's cardiac and vascular surgical procedures.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Artivion Inc revenues increased 18% to $298.8M. Net loss applicable to common stockholders decreased 11% to $14.7M. Revenues reflect Medical Devices segment increase of 24% to $221.6M, Preservation services segment increase of 4% to $77.2M, International segment increase of 28% to $147.7M, United States segment increase of 9% to $151.2M.
Equity composition
Common Stock $.01 Par, 03/11, 75M auth., 29,950,000 issd., less 2,053,000 shares in Treas. @ $11.7M. Insiders own 6.85% . IPO 2/93, 1.5M shs @ $10 by Robinson-Humphrey. PO 4/98, 2.75M shs (2.513M by Co.) @ $16.50 by SBC Warburg Dillon Read. 12/00, 3-for-2 split; 7/96, 2-for-1 split. FY'01 Qs are restated.
Industry: | Medical Equipment, Supplies & Distribution (NEC) |
1655 Roberts Boulevard N W
KENNESAW
GEORGIA 30144
US
Income Statement
- Annual
- Quarterly
News

S&P 500 & DAX 40 Forecast for the Week Ahead
S&P 500 builds higher after Fed meeting, DAX 40 runs into resistance
16:30, 3 February 2023
FX Weekly Outlook: USD, GBP/USD, USD/JPY Analysis
USD, GBP/USD, USD/JPY forecasts for the week ahead.
15:56, 3 February 2023
GBP/USD drops below 1.23 as BOE comments suggest possible end of rate hikes
Despite increasing rates by 50bps at their February meeting, the messaging from the BOE suggests a dovish tilt an the possible end of rate hikes.
15:37, 2 February 2023
Gold latest: XAU/USD rallies on Fed meeting as traders eye Friday’s jobs data
Gold buyers take advantage of risk on sentiment as they eye Friday's NFP data to assess the likelihood of a soft landing
11:48, 2 February 2023
British Pound (GBP) Outlook: GBP/USD, EUR/GBP Ahead of BoE Rate Decision
Bank of England remains a dovish hiker. GBP at risk of another dovish twist
15:13, 1 February 2023People also watch
Still looking for a broker you can trust?
Join the 480.000+ traders worldwide that chose to trade with Capital.com